Bachmann’s Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy
Table 3
Procedure results and clinical outcomes of patients with persistent AF after propensity score matching.
Total (168)
CPVI (n = 84)
CPVI-BB (n = 84)
value
Ablation time
86.53 ± 16.26
83.35 ± 14.77
89.18 ± 17.06
0.049
Procedure-related complications
3 (1.8%)
2 (2.4%)
1 (1.2%)
1.000
Clinical outcomes
Clinical recurrence
39 (23.2%)
25 (29.8%)
14 (16.7%)
0.044
AFL or AT recurrence
3 (1.8%)
2 (2.4%)
1 (1.2%)
1.000
Early recurrence
37 (22.0%)
22 (26.2%)
15 (17.9%)
0.193
AAD after blanking period
46 (27.4%)
30 (35.7%)
16 (19.0%)
0.015
Values are reported as mean ± standard deviation or n (%). AF: atrial fibrillation; AFL: atrial flutter; AT: atrial tachyarrhythmias; AAD: antiarrhythmic drugs.
